Viewing Study NCT02134912


Ignite Creation Date: 2025-12-26 @ 10:19 PM
Ignite Modification Date: 2026-02-25 @ 3:46 AM
Study NCT ID: NCT02134912
Status: TERMINATED
Last Update Posted: 2020-02-20
First Post: 2014-05-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib
Sponsor: SWOG Cancer Research Network
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: S1300
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View